UNILABS A/S: Financial statements 2024
CVR: 29458219
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
UNILABS A/S (CVR 29458219) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 88,839,000 and a net result of DKK 44,593,000 compared with DKK 27,652,000 the year before. That is an increase of 26.6% compared with the year before. Equity in the 2024 report amounted to DKK 52,324,000. The solvency ratio was 51.9%. The company had 50 employees in the financial year.
- Gross Profit
- DKK 88,839,000
- Profit/Loss
- DKK 44,593,000
- Equity
- DKK 52,324,000
- Total Assets
- DKK 100,837,000
- Employees
- 50
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 88.8 mio. | 44.6 mio. | 52.3 mio. | 50 |
| 2023 | - | 70.1 mio. | 27.7 mio. | 167.7 mio. | 46 |
| 2022 | - | 67.8 mio. | 18.2 mio. | 140.1 mio. | 48 |
| 2021 | - | 59.9 mio. | 16.1 mio. | 121.9 mio. | 55 |
| 2020 | - | 50 mio. | 9.3 mio. | 105.8 mio. | 59 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 10, 2024, Dhilum Alacon has joined the board of directors of UNILABS A/S.
As of July 10, 2024, Dhilum Alacon is registered as adm. dir. of UNILABS A/S.
As of July 1, 2024, Peder Søren Andersen has left the board of directors of UNILABS A/S.
As of July 1, 2024, Peder Søren Andersen has stepped down as director of UNILABS A/S.
UNILABS A/S has published its annual report for 2023. Gross profit came to DKK 70,149,000, and the net result was DKK 27,652,000.
As of June 21, 2024, Kristine Bøje Carstensen has joined the board of directors of UNILABS A/S.
As of June 21, 2024, Thomas Axel Per Lindahl has joined the board of directors of UNILABS A/S.
As of June 20, 2024, Thomas Axel Per Lindahl has left the board of directors of UNILABS A/S.
About UNILABS A/S
UNILABS A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named CAPIO DIAGNOSTIK A/S and NOVA MEDICAL MEDI-LAB A/S. The management consists of Amar Rauf. The board consists of Thomas Axel Per Lindahl (chair), Amar Rauf and Eric Schuh. The company is owned by Unilabs Laboratoire d'Analyses Médicales SA. The company has 47 employees (2026). In 2025, the company reported a gross profit of DKK 74,330,000 and a net result of DKK 37,726,000 compared with DKK 44,593,000 the year before. Equity in the 2025 report amounted to DKK 90,050,000.